North Carolina H624 mandates transparency in prescription drug pricing and requires manufacturers to notify interested parties of price changes.

North Carolina H624 aims to enhance transparency in prescription drug pricing by requiring manufacturers to notify interested parties of substantial price increases and the prices of new drugs. Manufacturers must provide justifications, marketing budgets, and acquisition details for these changes. The Secretary of Health and Human Services is tasked with developing a plan for data collection on drug costs and implementing an online portal for public access to required notifications and reports.

North Carolina H624 mandates transparency in prescription drug pricing and requires manufacturers to notify interested parties of price changes.

North Carolina H624 aims to enhance transparency in prescription drug pricing by requiring manufacturers to notify interested parties of substantial price increases and the prices of new drugs. Manufacturers must provide justifications, marketing budgets, and acquisition details for these changes. The Secretary of Health and Human Services is tasked with developing a plan for data collection on drug costs and implementing an online portal for public access to required notifications and reports.